Optimal Nutritional Palliation of Obstructed GEJ Cancer

NCT06876454 · tracked via the Priya Life Science Canada tracker

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase

Not applicable

Started

2025-07-01

Last updated

2025-05-25

Condition(s) studied

Esophageal Cancer

Investigational drug(s) / intervention(s)

Gastrostomy TubeSelf Expanding Metal esophageal Stent

Gastrostomy Tube: Feeding gastrostomy tube insertion

Self Expanding Metal esophageal Stent: Fully covered SEMS in the esophagus

Study summary

The main goal of this trial is to assess whether it's feasible to conduct a larger, full-scale study comparing the use of gastrostomy (g-tubes) and stents in patients with unresectable cancer of the stomach and/or esophagus, and to evaluate their impact on patients' quality of life. Additional objectives include examining the rates of complications, the need for additional treatments, and the total number of hospital days over a three-month period.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Patients aged 18 years of age and older who present with an obstructing metastatic or unresectable gastroesophageal cancer. Exclusion Criteria: * Patients under the age of 18 years. * Prior Esophageal Stent or gastrostomy tube

Primary outcome measure(s)

FACT-E — 3 months
• Change in FACT-E scores

Trial sites (1)

Facility	City	Region	Status
London Health Sciences Centre - Victoria Hospital	London	Ontario

More London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's trials in Canada

Pramipexole and the Risk of Serious Adverse Events Active, not recruiting

Fluid Intake After Hemodialysis Recruiting

Intermittent Fasting for Inflammation and Depression in Spinal Cord Injury Starting soon

Extracorporeal Photopheresis in Early Diffuse Cutaneous Systemic Sclerosis Starting soon

Ambroxol as a Novel Disease Modifying Treatment for Lewy Body Dementia Starting soon

Other trials for the same condition

Outside the Cage (OTC) Robotic Esophagectomy Starting soon

ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) Active, not recruiting

A Study Involving Neoadjuvant Chemoradiotherapy with Hypofractionated Radiotherapy in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma Recruiting

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2 Recruiting

Chemoradiotherapy for Advanced Esophageal Cancer Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06876454 on ClinicalTrials.gov ↗ ← All trials in Canada